Metastatic Colorectal Cancers Completed Phase 3 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01103323Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyTreatment